Nanoparticle-Mediated Gene Delivery to Cancer Cells
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 20 May 2024 | Viewed by 167
Special Issue Editors
Interests: nanomedicine; nanoparticle; biomaterials; gene therapy; cancer treatments
Interests: Gene therapy (of oral cancer); photodynamic therapy (of oral cancer; bacteriophage therapy (of mycobacterium infections); HIV eradication (via suicide gene therapy); nanomedicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Unrepaired genetic mutation is the fundamental root of cancers, providing unchecked survival and proliferative advantages to cancer cells. Gene therapy has attracted tremendous interest in the field of cancer treatments, as it offers vast versatility to cancer treatments due to its capability of encoding for virtually unlimited protein designs, which enables the modulation of crucial genes involved in tumor growth, immune response, and drug resistance. Nanoparticle-mediated gene delivery to cancer cells represents a promising frontier in anticancer gene therapy by harnessing the power of nanotechnology to enhance the stability and bioavailability of the genetic material, ensuring its safe and efficient delivery to cancer cells. Additionally, nanoparticle-mediated gene delivery can be combined with other cancer therapies, such as chemotherapy or immunotherapy, to create synergistic treatment strategies. Ongoing research in this field aims to optimize nanoparticle design, increase delivery efficiency, and develop safe and effective therapies for various cancer types.
Dr. Guanyou Lin
Prof. Dr. Nejat Düzgüneş
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- targeted gene delivery
- non-viral gene vectors
- RNA interference
- DNA/mRNA delivery
- delivery of tumor-specific genes
- combinatorial gene therapy
- theranostic nanoparticles
- nanoparticle modification for gene delivery
- controlled release of genetic cargos.
